903 resultados para MRT,voxel-dosimetry,terapia radiometabolica
Resumo:
Il presente lavoro di tesi nasce in seguito all’esperienza di tirocinio svolta presso l’Arcispedale Santa Maria Nuova di Reggio Emilia. Fulcro di questo lavoro è lo sviluppo di un sistema di pianificazione della dose per il trattamento dei pazienti sottoposti a Molecular Radionuclide Therapy (MRT). Presso tale struttura ospedaliera è già stato sviluppato uno strumento che si appoggia all’ambiente di lavoro Matlab per il calcolo dosimetrico. Tale programma è chiamato VoxelMed. Si tratta di uno strumento di calcolo che lavora al così detto voxel-level, tecnica di sviluppo recente che permette il calcolo della dose assorbita all’interno di un paziente in modo più dettagliato rispetto ai metodi di calcolo basati unicamente sulla stima media per organo, tipicamente impiegati in dosimetria tradizionale. Parte del lavoro di tesi consiste nell’implementare nuove modalità di calcolo ed aggiungere ulteriori accorgimenti all’attuale versione di VoxelMed. In VoxelMed è stata poi integrata ex-novo una componente di calcolo di misure radiobiologiche, in particolare della BED. La dose assorbita non è infatti un parametro sufficiente per valutare gli effetti della radiazione sui tessuti, a parità di tipo ed energia della radiazione gli effetti possono essere molto variabili. La BED è il parametro che tiene conto della risposta del tessuto sano o cancerogeno alla radiazione. Parte del lavoro è stato svolto sperimentalmente, tramite misure con fantocci acquisiti o preparati ad hoc. In particolare si sono utilizzati diverse tipologie di fantocci, per effettuare protocolli di calibrazione dei sistemi di acquisizione, misure di curve di effetto di volume parziale e test finali di verifica. Per un ulteriore verifica delle prestazioni di calcolo si sono effettuate misurazioni su un gruppo di pazienti e si sono confrontati i risultati con quelli ottenuti dal software maggiormente utilizzato nella pratica clinica, OLINDA/EXM.
Resumo:
Preclinical and clinical studies have indicated that somatostatin receptor (sst)-expressing tumors demonstrate higher uptake of radiolabeled sst antagonists than of sst agonists. In 4 consecutive patients with advanced neuroendocrine tumors, we evaluated whether treatment with (177)Lu-labeled sst antagonists is feasible. METHODS After injection of approximately 1 GBq of (177)Lu-DOTA-[Cpa-c(DCys-Aph(Hor)-DAph(Cbm)-Lys-Thr-Cys)-DTyr-NH2] ((177)Lu-DOTA-JR11) and (177)Lu-DOTATATE, 3-dimensional voxel dosimetry analysis based on SPECT/CT was performed. A higher tumor-to-organ dose ratio for (177)Lu-DOTA-JR11 than for (177)Lu-DOTATATE was the prerequisite for treatment with (177)Lu-DOTA-JR11. RESULTS Reversible minor adverse effects of (177)Lu-DOTA-JR11 were observed. (177)Lu-DOTA-JR11 showed a 1.7-10.6 times higher tumor dose than (177)Lu-DOTATATE. At the same time, the tumor-to-kidney and tumor-to-bone marrow dose ratio was 1.1-7.2 times higher. All 4 patients were treated with (177)Lu-DOTA-JR11, resulting in partial remission in 2 patients, stable disease in 1 patient, and mixed response in the other patient. CONCLUSION Treatment of neuroendocrine tumors with radiolabeled sst antagonists is clinically feasible and may have a significant impact on peptide receptor radionuclide therapy.
Resumo:
The outcomes for both (i) radiation therapy and (ii) preclinical small animal radio- biology studies are dependent on the delivery of a known quantity of radiation to a specific and intentional location. Adverse effects can result from these procedures if the dose to the target is too high or low, and can also result from an incorrect spatial distribution in which nearby normal healthy tissue can be undesirably damaged by poor radiation delivery techniques. Thus, in mice and humans alike, the spatial dose distributions from radiation sources should be well characterized in terms of the absolute dose quantity, and with pin-point accuracy. When dealing with the steep spatial dose gradients consequential to either (i) high dose rate (HDR) brachytherapy or (ii) within the small organs and tissue inhomogeneities of mice, obtaining accurate and highly precise dose results can be very challenging, considering commercially available radiation detection tools, such as ion chambers, are often too large for in-vivo use.
In this dissertation two tools are developed and applied for both clinical and preclinical radiation measurement. The first tool is a novel radiation detector for acquiring physical measurements, fabricated from an inorganic nano-crystalline scintillator that has been fixed on an optical fiber terminus. This dosimeter allows for the measurement of point doses to sub-millimeter resolution, and has the ability to be placed in-vivo in humans and small animals. Real-time data is displayed to the user to provide instant quality assurance and dose-rate information. The second tool utilizes an open source Monte Carlo particle transport code, and was applied for small animal dosimetry studies to calculate organ doses and recommend new techniques of dose prescription in mice, as well as to characterize dose to the murine bone marrow compartment with micron-scale resolution.
Hardware design changes were implemented to reduce the overall fiber diameter to <0.9 mm for the nano-crystalline scintillator based fiber optic detector (NanoFOD) system. Lower limits of device sensitivity were found to be approximately 0.05 cGy/s. Herein, this detector was demonstrated to perform quality assurance of clinical 192Ir HDR brachytherapy procedures, providing comparable dose measurements as thermo-luminescent dosimeters and accuracy within 20% of the treatment planning software (TPS) for 27 treatments conducted, with an inter-quartile range ratio to the TPS dose value of (1.02-0.94=0.08). After removing contaminant signals (Cerenkov and diode background), calibration of the detector enabled accurate dose measurements for vaginal applicator brachytherapy procedures. For 192Ir use, energy response changed by a factor of 2.25 over the SDD values of 3 to 9 cm; however a cap made of 0.2 mm thickness silver reduced energy dependence to a factor of 1.25 over the same SDD range, but had the consequence of reducing overall sensitivity by 33%.
For preclinical measurements, dose accuracy of the NanoFOD was within 1.3% of MOSFET measured dose values in a cylindrical mouse phantom at 225 kV for x-ray irradiation at angles of 0, 90, 180, and 270˝. The NanoFOD exhibited small changes in angular sensitivity, with a coefficient of variation (COV) of 3.6% at 120 kV and 1% at 225 kV. When the NanoFOD was placed alongside a MOSFET in the liver of a sacrificed mouse and treatment was delivered at 225 kV with 0.3 mm Cu filter, the dose difference was only 1.09% with use of the 4x4 cm collimator, and -0.03% with no collimation. Additionally, the NanoFOD utilized a scintillator of 11 µm thickness to measure small x-ray fields for microbeam radiation therapy (MRT) applications, and achieved 2.7% dose accuracy of the microbeam peak in comparison to radiochromic film. Modest differences between the full-width at half maximum measured lateral dimension of the MRT system were observed between the NanoFOD (420 µm) and radiochromic film (320 µm), but these differences have been explained mostly as an artifact due to the geometry used and volumetric effects in the scintillator material. Characterization of the energy dependence for the yttrium-oxide based scintillator material was performed in the range of 40-320 kV (2 mm Al filtration), and the maximum device sensitivity was achieved at 100 kV. Tissue maximum ratio data measurements were carried out on a small animal x-ray irradiator system at 320 kV and demonstrated an average difference of 0.9% as compared to a MOSFET dosimeter in the range of 2.5 to 33 cm depth in tissue equivalent plastic blocks. Irradiation of the NanoFOD fiber and scintillator material on a 137Cs gamma irradiator to 1600 Gy did not produce any measurable change in light output, suggesting that the NanoFOD system may be re-used without the need for replacement or recalibration over its lifetime.
For small animal irradiator systems, researchers can deliver a given dose to a target organ by controlling exposure time. Currently, researchers calculate this exposure time by dividing the total dose that they wish to deliver by a single provided dose rate value. This method is independent of the target organ. Studies conducted here used Monte Carlo particle transport codes to justify a new method of dose prescription in mice, that considers organ specific doses. Monte Carlo simulations were performed in the Geant4 Application for Tomographic Emission (GATE) toolkit using a MOBY mouse whole-body phantom. The non-homogeneous phantom was comprised of 256x256x800 voxels of size 0.145x0.145x0.145 mm3. Differences of up to 20-30% in dose to soft-tissue target organs was demonstrated, and methods for alleviating these errors were suggested during whole body radiation of mice by utilizing organ specific and x-ray tube filter specific dose rates for all irradiations.
Monte Carlo analysis was used on 1 µm resolution CT images of a mouse femur and a mouse vertebra to calculate the dose gradients within the bone marrow (BM) compartment of mice based on different radiation beam qualities relevant to x-ray and isotope type irradiators. Results and findings indicated that soft x-ray beams (160 kV at 0.62 mm Cu HVL and 320 kV at 1 mm Cu HVL) lead to substantially higher dose to BM within close proximity to mineral bone (within about 60 µm) as compared to hard x-ray beams (320 kV at 4 mm Cu HVL) and isotope based gamma irradiators (137Cs). The average dose increases to the BM in the vertebra for these four aforementioned radiation beam qualities were found to be 31%, 17%, 8%, and 1%, respectively. Both in-vitro and in-vivo experimental studies confirmed these simulation results, demonstrating that the 320 kV, 1 mm Cu HVL beam caused statistically significant increased killing to the BM cells at 6 Gy dose levels in comparison to both the 320 kV, 4 mm Cu HVL and the 662 keV, 137Cs beams.
Resumo:
Il presente lavoro è stato svolto presso la struttura di Fisica Medica dell'Azienda Ospedaliera IRCCS "Arcispedale S. Maria Nuova" di Reggio Emilia e consiste nello sviluppo di un sistema per l'ottimizzazione della dose in Radioterapia tramite dose-painting basato sui voxel. Il dose painting è una tecnica di pianificazione del trattamento di radioterapia che si basa sull'assegnazione o ridistribuzione della dose secondo le informazioni biologiche e metaboliche che i moderni sistemi di imaging sono in grado di fornire. La realizzazione del modulo di calcolo BioOPT è stata possibile grazie all'utilizzo dei due software open-source Plastimatch e CERR, specifici per l'elaborazione e la registrazione di immagini mediche di diversi tipi e formati e per la gestione, la modifica e il salvataggio di piani di trattamento di radioterapia creati con la maggior parte dei software commerciali ed accademici. Il sistema sviluppato è in grado di registrare le immagini relative ad un paziente, in generale ottenute da diverse tipologie di imaging e acquisite in tempi diversi ed estrarre le informazioni biologiche relative ad una certa struttura. Tali informazioni verranno poi utilizzate per calcolare le distribuzioni di dose "ottimale" che massimizzano il valore delle funzioni radiobiologiche utilizzate per guidare il processo di redistribuzione della dose a livello dei voxel (dose-painting). In questo lavoro il modulo è stato utilizzato principalmente per l'ottimizzazione della dose in pazienti affetti da Glioblastoma, un tumore cerebrale maligno tra i più diffusi e mortali. L'ottimizzatore voxel-based, infatti, è stato sviluppato per essere utilizzabile all'interno di un progetto di ricerca finanziato dal Ministero della Salute per la valutazione di un programma di terapia che include l'uso di un innovativo acceleratore lineare ad alto rateo di dose per la cura di tumori cerebrali in fase avanzata. Al fine di migliorare il trattamento radiante, inoltre, lo studio include la somministrazione della dose tramite dose-painting con lo scopo di verificarne l'efficacia. I risultati ottenuti mostrano che tramite il modulo sviluppato è possibile ottenere distribuzioni di dose eterogenee che tengono conto delle caratteristiche biologiche intratumore stimate a partire dalle immagini multimodali. Inoltre il sistema sviluppato, grazie alla sua natura 'open', è altamente personalizzabile a scopi di ricerca e consente di simulare distribuzioni di dose basate sui voxel e di confrontarle con quelle ottenute con i sistemi commerciali ad uso clinico, che non consentono questo tipo di ottimizzazioni.
Resumo:
The iPlan treatment planning sys-tem uses a pencil beam algorithm, with density cor-rections, to predict the doses delivered by very small (stereotactic) radiotherapy fields. This study tests the accuracy of dose predictions made by iPlan, for small-field treatments delivered to a planar solid wa-ter phantom and to heterogeneous human tissue using the BrainLAB m3 micro-multileaf collimator.
Resumo:
In this feasibility study an organic plastic scintillator is calibrated against ionisation chamber measurements and then embedded in a polymer gel dosimeter to obtain a quasi-4D experimental measurement of a radiation field. This hybrid dosimeter was irradiated with a linear accelerator, with temporal measurements of the dose rate being acquired by the scintillator and spatial measurements acquired with the gel dosimeter. The detectors employed in this work are radiologically equivalent; and we show that neither detector perturbs the intensity of the radiation field of the other. By employing these detectors in concert, spatial and temporal variations in the radiation intensity can now be detected and gel dosimeters can be calibrated for absolute dose from a single irradiation.
Resumo:
This study uses dosimetry film measurements and Monte Carlo simulations to investigate the accuracy of type-a (pencil-beam) dose calculations for predicting the radiation doses delivered during stereotactic radiotherapy treatments of the brain. It is shown that when evaluating doses in a water phantom, the type-a algorithm provides dose predictions which are accurate to within clinically relevant criteria, gamma(3%,3mm), but these predictions are nonetheless subtly different from the results of evaluating doses from the same fields using radiochromic film and Monte Carlo simulations. An analysis of a clinical meningioma treatment suggests that when predicting stereotactic radiotherapy doses to the brain, the inaccuracies of the type-a algorithm can be exacerbated by inadequate evaluation of the effects of nearby bone or air, resulting in dose differences of up to 10% for individual fields. The results of this study indicate the possible advantage of using Monte Carlo calculations, as well as measurements with high-spatial resolution media, to verify type-a predictions of dose delivered in cranial treatments.